By Lisa Howard While the SARS-CoV-2 virus has dominated the news this past year, researchers continue to study the health effects of the Zika virus, which has been reported in 86 countries globally. The Zika virus is primarily transmitted by the bite of an infected mosquito from the Aedes genus. However, it can also be passed through […]
By Lisa Howard Over the past 10 months, K-12 school districts in California have faced unprecedented challenges due to the COVID-19 pandemic. To help reduce the spread of the virus in spring 2020, districts largely transitioned to distance-learning, with some or all of the instruction happening online. To understand the potential impact of these instructional […]
By Lisa Howard Shasqi, a startup enabled with technology developed at the University of California, Davis, and the State University of New York at Albany, has launched a Phase 1 human clinical trial of its precision activated oncology therapeutic. Shasqi is a privately held, clinical-stage biotechnology company with a mission of developing precision activated oncology […]
Updated December 7, 2020 UC Davis has announced a Davis campus curtailment program for six workdays between December 21, 2020, and January 4, 2021. Although the campus has modified the curtailment from a hard closure to a soft closure, the Office of Research will continue with its original plan. Please submit all routine or known […]
By Lisa Howard Bouillon is a staple ingredient in West African cuisine. The cubes are used to flavor soups, stews, gravies and rice. Popular dishes include Red-Red, a bean stew made with red palm oil and fried ripe red plantain, and Jollof Rice, a spicy rice dish prepared with tomatoes, peppers and onions. Seth Adu-Afarwuah’s […]
Last week, Jennifer Doudna, the 2020 Nobel Laureate in Chemistry, gave a fascinating talk to an online audience of more than 1,600 viewers. She shared her journey in co-developing the powerful genome-editing technology CRISPR and its potential to improve diagnosis and treatment of COVID-19. Doudna’s co-discovery of CRISPR-Cas9 genetic engineering technology has disrupted human and […]
Considering the current infection trends in Yolo and Sacramento counties, we will not be moving on to Phase 3 until our saliva testing facility scales up. However, we will have an incremental research ramp-up to Phase 2x effective October 30, 2020. Details of the Phase 2 were shared in our earlier guidance. Implementations of the […]
